Association between CNS-active drugs and risk of Alzheimer’s and age-related neurodegenerative diseases
ObjectiveAs neuropsychiatric conditions can increase the risk of age-related neurodegenerative diseases (NDDs), the impact of CNS-active drugs on the risk of developing Alzheimer’s Disease (AD), non-AD dementia, Multiple Sclerosis (MS), Parkinson’s Disease (PD) and Amyotrophic Lateral Sclerosis (ALS...
Main Authors: | Helena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1358568/full |
Similar Items
-
Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients
by: Georgina Torrandell-Haro, et al.
Published: (2022-05-01) -
Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics
by: Gregory L. Branigan, et al.
Published: (2022-10-01) -
Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy
by: Yu Jin Kim, et al.
Published: (2021-01-01) -
Triad of Risk for Late Onset Alzheimer’s: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex
by: Yiwei Wang, et al.
Published: (2016-10-01) -
Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer’s disease
by: Steven Jett, et al.
Published: (2022-07-01)